MJMaria Camila Jiménez

Maria Camila Jiménez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Maria Camila Jiménez has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Alfonso Barreto

    Grupo de Inmunobiología y Biología celular, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá, Colombia

    3 shared publications
  • Susana Fiorentino

    Grupo de Inmunobiología y Biología celular, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá 110231, Colombia

    2 shared publications
  • Ana Corredor

    Inmunohematología, Fundación Santa Fe de Bogotá, Bogotá, D.C., Colombia

    1 shared publication
  • B. S. Rivera

    Grupo Ingeniería de Tejidos y Terapías Celulares, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia

    1 shared publication
  • Claudia Camila Mejía-Cruz

    Immunobiology and Cell Biology Group, Department of Microbiology, Science Faculty, Pontificia Universidad Javeriana, Bogotá D.C., Colombia

    1 shared publication
  • Efrain Leal-García

    Department of Orthopedics and Traumatology, School of Medicine, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá D.C., Colombia

    1 shared publication

Latest Publications

  • Open Access

    Tillandsia usneoides Ethanolic Extract Induces Cytotoxicity in SW480 Colon Cancer Cell Line via PPARγ Modulation

    by María Paula López, María Camila Jiménez, Julián Esteban Contreras, Laura Rojas, Susana Fiorentino, José Iglesias

    Colorectal cancer (CRC) is a prevalent and deadly tumor worldwide. Understanding the molecular mechanisms underlying CRC development will improve treatment outcomes and patient survival. Natural molecules and metabolites from plants, such as Tillandsia usneoides, reduce tumor growth by modulating glucose metabolism and increasing reactive oxygen species (ROS). To shed light on the mechanism involved in the anti-tumor effects of T. usneoides, we evaluated the cytotoxic effect of the ethanolic extract of this plant on the colon cancer cell line SW480 through the activation of the peroxisome proliferator-activated receptor gamma (PPARγ), a nuclear receptor that plays a role on lipid metabolism and inflammation in cancer cells. To this end, we assessed the activation of PPARγ by T. usneoides extract in transactivation luciferase assays, as well as the cytotoxic effect of this extract on the SW480 cell line after knocking down PPARγ using shRNA. Our findings indicate that the T. usneoides extract exhibits cytotoxic effects on the SW480 cell line, potentially in the same way as PPARγ activator, pioglitazone, i.e., by increasing reactive oxygen species (ROS). In addition, both T. usneoides extract and pioglitazone exert lipogenic properties in the SW480 cells. Taken together, these results demonstrate that the T. usneoides extract decreases the viability of the colon cancer cell line SW480, at least in part, through the activation of PPARγ. This suggests the potential for further use of this plant in the treatment of other chronic diseases.

  • Open Access

    The secretome from human-derived mesenchymal stem cells augments the activity of antitumor plant extracts in vitro

    by J. A. Ramirez, M. C. Jiménez, V. Ospina, B. S. Rivera, S. Fiorentino, A. Barreto, L. M. Restrepo

    Cancer is understood as a multifactorial disease that involve multiple cell types and phenotypes in the tumor microenvironment (TME). The components of the TME can interact directly or via soluble factors (cytokines, chemokines, growth factors, extracellular vesicles, etc.). Among the cells composing the TME, mesenchymal stem cells (MSCs) appear as a population with debated properties since it has been seen that they can both promote or attenuate tumor progression. For various authors, the main mechanism of interaction of MSCs is through their secretome, the set of molecules secreted into the extracellular milieu, recruiting, and influencing the behavior of other cells in inflammatory environments where they normally reside, such as wounds and tumors. Natural products have been studied as possible cancer treatments, appealing to synergisms between the molecules in their composition; thus, extracts obtained from Petiveria alliacea (Anamu-SC) and Caesalpinia spinosa (P2Et) have been produced and studied previously on different models, showing promising results. The effect of plant extracts on the MSC secretome has been poorly studied, especially in the context of the TME. Here, we studied the effect of Anamu-SC and P2Et extracts in the human adipose-derived MSC (hAMSC)–tumor cell interaction as a TME model. We also investigated the influence of the hAMSC secretome, in combination with these natural products, on tumor cell hallmarks such as viability, clonogenicity, and migration. In addition, hAMSC gene expression and protein synthesis were evaluated for some key factors in tumor progression in the presence of the extracts by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Multiplex, respectively. It was found that the presence of the hAMSC secretome did not affect the cytotoxic or clonogenicity-reducing activities of the natural extracts on cancer cells, and even this secretome can inhibit the migration of these tumor cells, in addition to the fact that the profile of molecules can be modified by natural products. Overall, our findings demonstrate that hAMSC secretome participation in TME interactions can favor the antitumor activities of natural products.


  • Open Access

    Plant extract from Caesalpinia spinosa inhibits cancer-associated fibroblast-like cells generation and function in a tumor microenvironment model

    by Maria Camila Jiménez, Karol Prieto, Paola Lasso, Melisa Gutiérrez, Viviana Rodriguez-Pardo, Susana Fiorentino, Alfonso Barreto


  • Open Access

    Enfermedad hemolítica del feto y del recién nacido por aloanticuerpos contra el antígeno M

    by Marco Páez, María Jiménez, Ana Corredor

    Hay pocos reportes de enfermedad hemolítica del feto y del recién nacido causada por aloanticuerpos contra el sistema de antígenos MNS, especialmente, porque los anticuerpos que se generan contra estos antígenos son del tipo IgM, los cuales tienen reactividad a temperaturas inferiores a los 37 °C, y, por lo tanto, no son de importancia clínica. A pesar de ello, se han reportado casos con presencia de anticuerpos anti-M de tipo IgG causantes de la enfermedad hemolítica del recién nacido e, incluso, casos de muerte intrauterina por incompatibilidad materno-fetal en el sistema MNS. El proceso hemolítico se asemeja al causado por los anticuerpos anti-Kell, con anemia progresiva por supresión hematopoyética que induce la destrucción de precursores hematopoyéticos en la médula ósea y ausencia de reticulocitos en la periferia.Se reporta el caso de una mujer con 38,5 semanas de gestación, que presentó discrepancia en la hemoclasificación directa y en la inversa. Como resultado, el recién nacido fue positivo en la prueba de Coombs directa sin que existiera incompatibilidad ABO con la madre. La correlación de estos resultados llevó a la detección de un anticuerpo anti-M en el suero materno. El diagnóstico definitivo fue posible gracias a la discrepancia en la hemoclasificación de la sangre materna. A pesar de que los anticuerpos anti-M usualmente no desempeñan un papel importante en la enfermedad hemolítica perinatal, este caso resalta la importancia de determinar la presencia de diferentes anticuerpos que pueden ser de interés a la hora de prevenir resultados graves asociados con dicha condición.


  • Open Access

    Generation of Organotypic Multicellular Spheres by Magnetic Levitation: Model for the Study of Human Hematopoietic Stem Cells Microenvironment

    by Claudia Camila Mejía-Cruz, Emilia Barreto-Durán, María Alejandra Pardo-Pérez, María Camila Jimenez, Julieth Rincón, Karen Vanegas, Jorge Luis Rodríguez, Luis Fernando Jaramillo-Garcia, Juan Carlos Ulloa, Rodolfo Martínez Díaz, et al.

    Claudia Camila Mejía-Cruz, Emilia Barreto-Durán, María Alejandra Pardo-Pérez, María Camila Jimenez, Julieth Rincón, Karen Vanegas, Jorge Luis Rodríguez, Luis Fernando Jaramillo-Garcia, Juan Carlos Ulloa, Rodolfo Martínez Díaz, Efrain Leal-García, Rafael Pérez-Núñez, Alfonso Barreto, Viviana M Rodríguez-Pardo. IJSC 1999;0:. https://doi.org/10.15283/ijsc18061